MAPT and supranuclear palsy, progressive, 1: Two haplotypes have been identified for MAPT. The H1 haplotype is associated with increased risk of PSP, CBD and PD [6, 18, 90], whereas the H2 haplotype rs870723-G allele is associated with decreased risk of late-onset AD [3].